Seqens Seqens

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of MolPort-001-740-041 on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
881
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 5MG
  • TABLET;ORAL - 10MG
  • TABLET;ORAL - 50MG
  • TABLET;ORAL - 20MG
  • TABLET;ORAL - 1MG
  • TABLET;ORAL - 2.5MG
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9040085
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8394407
Y
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9504699
2027-08-03
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9504699
2027-08-03
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8394407
Y
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8309124
2024-04-23
U-1292
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG PREDNISONE TABLET
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9040085
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9186332
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8394407
Y
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9186332
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8309124
2024-04-23
U-1292
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG PREDNISONE TABLET
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8309124
2024-04-23
202020
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9040085
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9504699
2027-08-03
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8168218
Y
2028-01-07
U-1269
202020
TREATMENT OF RHEUMATOLOGIC, ALLERGIC, PULMONARY, GASTROINTESTINAL, DERMATOLOGIC DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 5MG PREDNISONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
9186332
2024-04-23
U-1362
202020
TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY